RE: We Feel It’s Our Moment26 Apr 2020 22:55
I just listened to the Andrew Scott video. That has allot of data about learnings from COPD trials and he talks about the positive impact if using SNG001 on non effected high risk patients.
Synairgen are in a fantastic position given their twos years worth of learning from the Asthma and COPD trials. This data can also be used to help Build their technical folders.
The other win is the placebo trial. This adds significant weight to the trial and results.
I still don’t think most understand the history of this business and the amount of data they already have on SNG001.
IAmrich as you say, the treatment won’t work on everyone, it would be unrealistic to think that. Equally the vaccine wont work on everyone either. Close to 50 patients will now have received SNG001 and 50 the Placebo. Week 5 starts Monday. Data is now flowing daily into the business. This is now getting very interesting. Trading in and out of this will get higher risk by the day now.